June 30, 2025 · Form 4 insider transaction
Ostrowski Erik sold 41,314 shares of Akreion Pharma Co at $3.67 per share, a transaction worth $151.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 21, 2024.; This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on June 28, 2024.